设为首页 加入收藏

TOP

Vyndaqel 20mg（tafamidis meglumina）
2017-09-20 12:59:54 来源: 作者: 【大 中 小】 浏览:603次 评论:0条

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack Carton

Vyndaqel® 20 mg

tafamidis meglumina

Pfizer

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack Carton

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack

Vyndaqel® 20 mg

tafamidis meglumina
Pfizer

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack

INGREDIENTS AND APPEARANCE

 

VYNDAQEL  tafamidis meglumine capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0069-8729
Route of Administration ORAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TAFAMIDIS MEGLUMINE (UNII: ZU7CF08A1A) (TAFAMIDIS - UNII:8FG9H9D31J) TAFAMIDIS MEGLUMINE 20 mg
Inactive Ingredients
Ingredient Name Strength
GELATIN (UNII: 2G86QN327L)  
GLYCERIN (UNII: PDC6A3C0OX)  
SORBITOL (UNII: 506T60A25R)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
Product Characteristics
Color WHITE Score no score
Shape CAPSULE Size 10mm
Flavor   Imprint Code VYN20
Contains     
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0069-8729-55 1 in 1 CARTON 12/15/2015  
1   30 in 1 BLISTER PACK; Type 0: Not a Combination Product    
 
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
EXPORT ONLY   12/15/2015
以下是“全球医药”详细资料
Tags： 责任编辑：admin
【大 中 小】【打印】 【繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部】
分享到QQ空间
分享到: 
上一篇：GLIADEL WAFER (carmustine impla.. 下一篇：TREMFYA (guselkumab) injection,..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位